Is Zevra Therapeutics, Inc. (ZVRA) a Buy, Sell, or Hold?
NASDAQ : ZVRA
Zevra Therapeutics, Inc.
$12.77 USD
$0.01 (0.08%)
- Volume
- 623.22K
- Average Volume
- 1.69M
- Market Capitalization
- $754.9M
- P/E Ratio
- 5.86
- Dividend Yield
- 0.00%
- Price Target
- $29.00
- Year High
- $15.04
- Year Low
- $7.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.89
3333332"{?
p/.m7yd f,0=
Annual earnings financials
ZVRA financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
ZVRA Estimated and Actual Revenue by Quarter
ZVRA Estimated and Actual EPS by Quarter
ZVRA Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 2 | -35.81M | -30.4M | -32.59M | -36.53M | -31.01M | -33.24M |
| 2028-09-30 | 2 | -34.3M | -29.12M | -31.22M | -34.99M | -29.71M | -31.85M |
| 2028-06-30 | 2 | -32.12M | -27.27M | -29.23M | -32.76M | -27.81M | -29.82M |
| 2028-03-31 | 2 | -29.92M | -25.4M | -27.23M | -30.52M | -25.91M | -27.78M |
| 2027-12-31 | 3 | -25.08M | -21.3M | -22.83M | -25.59M | -21.72M | -23.28M |
| 2027-09-30 | 3 | -24.02M | -20.39M | -21.86M | -24.5M | -20.8M | -22.3M |
ZVRA Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 2 | 25.39M | 31.39M | 27.81M | 79.16M | 93.24M | 84.86M |
| 2028-09-30 | 2 | 23.9M | 29.55M | 26.18M | 75.83M | 89.32M | 81.29M |
| 2028-06-30 | 2 | 20.69M | 25.58M | 22.66M | 71M | 83.63M | 76.11M |
| 2028-03-31 | 2 | 17.49M | 21.62M | 19.16M | 66.14M | 77.91M | 70.9M |
| 2027-12-31 | 3 | 16.12M | 19.92M | 17.66M | 55.45M | 65.31M | 59.44M |
| 2027-09-30 | 3 | 15.12M | 18.69M | 16.57M | 53.1M | 62.54M | 56.92M |
ZVRA Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2028-12-31 | 2 | 64.74M | 76.25M | 69.4M | 1 | 0.4215 | 0.52112 | 0.4618 |
| 2028-09-30 | 2 | 62.01M | 73.04M | 66.48M | 1 | 0.39676 | 0.49054 | 0.4347 |
| 2028-06-30 | 2 | 58.06M | 68.39M | 62.24M | 1 | 0.34346 | 0.42464 | 0.3763 |
| 2028-03-31 | 2 | 54.09M | 63.71M | 57.98M | 1 | 0.29034 | 0.35896 | 0.3181 |
| 2027-12-31 | 3 | 45.34M | 53.41M | 48.61M | 1 | 0.26757 | 0.33081 | 0.29315 |
| 2027-09-30 | 3 | 43.42M | 51.15M | 46.55M | 1 | 0.25103 | 0.31036 | 0.27503 |